Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy
Identifieur interne : 001945 ( Main/Exploration ); précédent : 001944; suivant : 001946Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy
Auteurs : Yasuhiro Kawamoto [Japon] ; Ichiro Akiguchi [Japon] ; Shinichi Nakamura [Japon] ; Herbert Budka [Autriche]Source :
- Annals of Neurology [ 0364-5134 ] ; 2002-12.
Abstract
Glial cytoplasmic inclusions are the pathological hallmark of multiple system atrophy. However, the molecular mechanisms underlying the formation of glial cytoplasmic inclusions remain unclear. α‐Synuclein, a major component of glial cytoplasmic inclusions, has the ability to interact with 14‐3‐3 proteins, which mediate several types of signal transduction pathways. To elucidate the role of these 14‐3‐3 proteins in patients with multiple system atrophy, we performed immunohistochemical studies on 14‐3‐3 in brain tissue specimens from 7 control subjects and from 15 patients with multiple system atrophy. In both control and multiple system atrophy cases, 14‐3‐3 immunoreactivity was observed mainly in the neuronal somata and proximal processes, as well as the nerve fibers. Even in the severely affected regions of patients with multiple system atrophy, 14‐3‐3 immunoreactivity generally was spared in the surviving neurons, some of which were strongly immunolabeled. In addition, numerous glial cytoplasmic inclusions were intensely immunostained, and neuronal cytoplasmic inclusions and dystrophic neurites were also immunoreactive for 14‐3‐3. Our results suggest that an aberrant accumulation of 14‐3‐3 proteins may occur in brains affected by multiple system atrophy, and that 14‐3‐3 proteins may be associated with the pathogenesis of multiple system atrophy. Ann Neurol 2002;52:000–000
Url:
DOI: 10.1002/ana.10361
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy</title><author><name sortKey="Kawamoto, Yasuhiro" sort="Kawamoto, Yasuhiro" uniqKey="Kawamoto Y" first="Yasuhiro" last="Kawamoto">Yasuhiro Kawamoto</name></author><author><name sortKey="Akiguchi, Ichiro" sort="Akiguchi, Ichiro" uniqKey="Akiguchi I" first="Ichiro" last="Akiguchi">Ichiro Akiguchi</name></author><author><name sortKey="Nakamura, Shinichi" sort="Nakamura, Shinichi" uniqKey="Nakamura S" first="Shinichi" last="Nakamura">Shinichi Nakamura</name></author><author><name sortKey="Budka, Herbert" sort="Budka, Herbert" uniqKey="Budka H" first="Herbert" last="Budka">Herbert Budka</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8EFC0832271CFD84EC49DEFC7DDD4C688A4C756F</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/ana.10361</idno><idno type="url">https://api.istex.fr/document/8EFC0832271CFD84EC49DEFC7DDD4C688A4C756F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002542</idno><idno type="wicri:Area/Main/Curation">002208</idno><idno type="wicri:Area/Main/Exploration">001945</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy</title><author><name sortKey="Kawamoto, Yasuhiro" sort="Kawamoto, Yasuhiro" uniqKey="Kawamoto Y" first="Yasuhiro" last="Kawamoto">Yasuhiro Kawamoto</name><affiliation wicri:level="4"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Akiguchi, Ichiro" sort="Akiguchi, Ichiro" uniqKey="Akiguchi I" first="Ichiro" last="Akiguchi">Ichiro Akiguchi</name><affiliation wicri:level="4"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Nakamura, Shinichi" sort="Nakamura, Shinichi" uniqKey="Nakamura S" first="Shinichi" last="Nakamura">Shinichi Nakamura</name><affiliation wicri:level="4"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Budka, Herbert" sort="Budka, Herbert" uniqKey="Budka H" first="Herbert" last="Budka">Herbert Budka</name><affiliation wicri:level="3"><country xml:lang="fr">Autriche</country><wicri:regionArea>Institute of Neurology, University of Vienna, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Neurology</title><title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="ISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-12">2002-12</date><biblScope unit="volume">52</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="722">722</biblScope><biblScope unit="page" to="731">731</biblScope></imprint><idno type="ISSN">0364-5134</idno></series><idno type="istex">8EFC0832271CFD84EC49DEFC7DDD4C688A4C756F</idno><idno type="DOI">10.1002/ana.10361</idno><idno type="ArticleID">ANA10361</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0364-5134</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Glial cytoplasmic inclusions are the pathological hallmark of multiple system atrophy. However, the molecular mechanisms underlying the formation of glial cytoplasmic inclusions remain unclear. α‐Synuclein, a major component of glial cytoplasmic inclusions, has the ability to interact with 14‐3‐3 proteins, which mediate several types of signal transduction pathways. To elucidate the role of these 14‐3‐3 proteins in patients with multiple system atrophy, we performed immunohistochemical studies on 14‐3‐3 in brain tissue specimens from 7 control subjects and from 15 patients with multiple system atrophy. In both control and multiple system atrophy cases, 14‐3‐3 immunoreactivity was observed mainly in the neuronal somata and proximal processes, as well as the nerve fibers. Even in the severely affected regions of patients with multiple system atrophy, 14‐3‐3 immunoreactivity generally was spared in the surviving neurons, some of which were strongly immunolabeled. In addition, numerous glial cytoplasmic inclusions were intensely immunostained, and neuronal cytoplasmic inclusions and dystrophic neurites were also immunoreactive for 14‐3‐3. Our results suggest that an aberrant accumulation of 14‐3‐3 proteins may occur in brains affected by multiple system atrophy, and that 14‐3‐3 proteins may be associated with the pathogenesis of multiple system atrophy. Ann Neurol 2002;52:000–000</div></front></TEI><affiliations><list><country><li>Autriche</li><li>Japon</li></country><region><li>Région du Kansai</li><li>Vienne (Autriche)</li></region><settlement><li>Kyoto</li><li>Vienne (Autriche)</li></settlement><orgName><li>Université de Kyoto</li></orgName></list><tree><country name="Japon"><region name="Région du Kansai"><name sortKey="Kawamoto, Yasuhiro" sort="Kawamoto, Yasuhiro" uniqKey="Kawamoto Y" first="Yasuhiro" last="Kawamoto">Yasuhiro Kawamoto</name></region><name sortKey="Akiguchi, Ichiro" sort="Akiguchi, Ichiro" uniqKey="Akiguchi I" first="Ichiro" last="Akiguchi">Ichiro Akiguchi</name><name sortKey="Nakamura, Shinichi" sort="Nakamura, Shinichi" uniqKey="Nakamura S" first="Shinichi" last="Nakamura">Shinichi Nakamura</name></country><country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Budka, Herbert" sort="Budka, Herbert" uniqKey="Budka H" first="Herbert" last="Budka">Herbert Budka</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001945 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001945 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8EFC0832271CFD84EC49DEFC7DDD4C688A4C756F
|texte= Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy
}}
| This area was generated with Dilib version V0.6.23. |  |